283 related articles for article (PubMed ID: 8917265)
1. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).
Gottlieb S; Boyko V; Zahger D; Balkin J; Hod H; Pelled B; Stern S; Behar S
J Am Coll Cardiol; 1996 Nov; 28(6):1506-13. PubMed ID: 8917265
[TBL] [Abstract][Full Text] [Related]
2. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Circulation; 1993 Jan; 87(1):53-8. PubMed ID: 8419024
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Haim M; Gottlieb S; Boyko V; Reicher-Reiss H; Hod H; Kaplinsky E; Mandelzweig L; Goldbourt U; Behar S
Am Heart J; 1998 Aug; 136(2):245-51. PubMed ID: 9704685
[TBL] [Abstract][Full Text] [Related]
4. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups.
Gottlieb S; Goldbourt U; Boyko V; Harpaz D; Mandelzweig L; Khoury Z; Stern S; Behar S
Eur Heart J; 2000 Feb; 21(4):284-95. PubMed ID: 10653676
[TBL] [Abstract][Full Text] [Related]
5. Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. Israeli Thrombolytic Survey Group.
Gottlieb S; Boyko V; Harpaz D; Hod H; Cohen M; Mandelzweig L; Khoury Z; Stern S; Behar S
J Am Coll Cardiol; 1999 Jul; 34(1):70-82. PubMed ID: 10399994
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Barbash GI; Reiner J; White HD; Wilcox RG; Armstrong PW; Sadowski Z; Morris D; Aylward P; Woodlief LH; Topol EJ
J Am Coll Cardiol; 1995 Nov; 26(5):1222-9. PubMed ID: 7594035
[TBL] [Abstract][Full Text] [Related]
7. Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era. SPRINT Study Group and the Israeli Thrombolytic Survey Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Harpaz D; Behar S; Gottlieb S; Boyko V; Kishon Y; Eldar M
J Am Coll Cardiol; 1999 Nov; 34(6):1721-8. PubMed ID: 10577562
[TBL] [Abstract][Full Text] [Related]
8. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
Gomez MA; Karagounis LA; Allen A; Anderson JL
Am J Cardiol; 1993 Aug; 72(5):373-8. PubMed ID: 8352177
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group.
Gottlieb S; Harpaz D; Shotan A; Boyko V; Leor J; Cohen M; Mandelzweig L; Mazouz B; Stern S; Behar S
Circulation; 2000 Nov; 102(20):2484-90. PubMed ID: 11076821
[TBL] [Abstract][Full Text] [Related]
10. Family history of coronary artery disease and prognosis after first acute myocardial infarction in a national survey.
Harpaz D; Behar S; Rozenman Y; Boyko V; Gottlieb S;
Cardiology; 2004; 102(3):140-6. PubMed ID: 15334023
[TBL] [Abstract][Full Text] [Related]
11. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction.
Grines CL; Topol EJ; O'Neill WW; George BS; Kereiakes D; Phillips HR; Leimberger JD; Woodlief LH; Califf RM
Circulation; 1995 Jan; 91(2):298-303. PubMed ID: 7805231
[TBL] [Abstract][Full Text] [Related]
12. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited.
Weisz G; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey TD; Rutherford BD; Mehran R; Aymong E; Lansky A; Grines CL; Stone GW
Am Heart J; 2005 Aug; 150(2):358-64. PubMed ID: 16086943
[TBL] [Abstract][Full Text] [Related]
13. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.
de Chillou C; Riff P; Sadoul N; Ethevenot G; Feldmann L; Isaaz K; Simon JP; Boursier M; Khalifé K; Thisse JY; Aliot E
J Am Coll Cardiol; 1996 Jun; 27(7):1662-8. PubMed ID: 8636551
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis.
Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K; Ueda K
Am Heart J; 1997 Nov; 134(5 Pt 1):955-60. PubMed ID: 9398109
[TBL] [Abstract][Full Text] [Related]
15. On-site catheterization laboratory and prognosis after acute myocardial infarction. Israeli Thrombolytic Survey Group.
Behar S; Hod H; Benari B; Narinsky R; Pauzner H; Rechavia E; Faibel HE; Katz A; Roth A; Goldhammer E
Arch Intern Med; 1995 Apr; 155(8):813-7. PubMed ID: 7717789
[TBL] [Abstract][Full Text] [Related]
16. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
[TBL] [Abstract][Full Text] [Related]
17. [Cigarette smoking and acute myocardial infarct].
Trappolini M; Matteoli S; Chillotti FM; Curione M; Del Vecchio LR; Puletti M
Minerva Cardioangiol; 1996 Dec; 44(12):609-16. PubMed ID: 9053813
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: the Israeli Thrombolytic National Survey.
Tanne D; Gottlieb S; Caspi A; Hod H; Palant A; Reisin L; Rosenfeld T; Peled B; Marmor AT; Balkin J; Boyko V; Behar S
Arch Intern Med; 1998 Mar; 158(6):601-6. PubMed ID: 9521224
[TBL] [Abstract][Full Text] [Related]
19. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
[TBL] [Abstract][Full Text] [Related]
20. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
Mueller HS; Cohen LS; Braunwald E; Forman S; Feit F; Ross A; Schweiger M; Cabin H; Davison R; Miller D
Circulation; 1992 Apr; 85(4):1254-64. PubMed ID: 1555269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
